206 related articles for article (PubMed ID: 17970617)
1. DNA interaction with novel antitumor estradiol-platinum(II) hybrid molecule: a comparative study with cisplatin drug.
N'soukpoé-Kossi CN; Descôteaux C; Asselin E; Tajmir-Riahi HA; Bérubé G
DNA Cell Biol; 2008 Feb; 27(2):101-7. PubMed ID: 17970617
[TBL] [Abstract][Full Text] [Related]
2. Transfer RNA bindings to antitumor estradiol-platinum(II) hybrid and cisplatin.
N'soukpoé-Kossi CN; Descôteaux C; Asselin E; Bariyanga J; Tajmir-Riahi HA; Bérubé G
DNA Cell Biol; 2008 Jun; 27(6):337-43. PubMed ID: 18447754
[TBL] [Abstract][Full Text] [Related]
3. A comparative study on the interaction of cis- and trans-platin with DNA and RNA.
Nafisi S; Norouzi Z
DNA Cell Biol; 2009 Sep; 28(9):469-77. PubMed ID: 19558218
[TBL] [Abstract][Full Text] [Related]
4. Study of DNA interactions with steroidal and nonsteroidal estrogen-platinum (II)-based anticancer drugs.
Froehlich E; Gupta A; Provencher-Mandeville J; Asselin E; Bariyanga J; Bérubé G; Tajmir-Riahi HA
DNA Cell Biol; 2009 Jan; 28(1):31-9. PubMed ID: 18928379
[TBL] [Abstract][Full Text] [Related]
5. Solution structural study of a DNA duplex containing the guanine-N7 adduct formed by a cytotoxic platinum-acridine hybrid agent.
Baruah H; Wright MW; Bierbach U
Biochemistry; 2005 Apr; 44(16):6059-70. PubMed ID: 15835895
[TBL] [Abstract][Full Text] [Related]
6. Binding of platinum derivative, oxaliplatin to deoxyribonucleic acid: structural insight into antitumor action.
Ray B; Gupta B; Mehrotra R
J Biomol Struct Dyn; 2019 Sep; 37(14):3838-3847. PubMed ID: 30282523
[TBL] [Abstract][Full Text] [Related]
7. Thymol and carvacrol binding to DNA: model for drug-DNA interaction.
Nafisi Sh; Hajiakhoondi A; Yektadoost A
Biopolymers; 2004 Aug; 74(5):345-51. PubMed ID: 15222014
[TBL] [Abstract][Full Text] [Related]
8. Different features of the DNA binding mode of antitumor cis-amminedichlorido(cyclohexylamine)platinum(II) (JM118) and cisplatin in vitro.
Kostrhunova H; Vrana O; Suchankova T; Gibson D; Kasparkova J; Brabec V
Chem Res Toxicol; 2010 Nov; 23(11):1833-42. PubMed ID: 20939593
[TBL] [Abstract][Full Text] [Related]
9. Spontaneous translocation of antitumor oxaliplatin, its enantiomeric analogue, and Cisplatin from one strand to another in double-helical DNA.
Malina J; Natile G; Brabec V
Chemistry; 2013 Sep; 19(36):11984-91. PubMed ID: 23873652
[TBL] [Abstract][Full Text] [Related]
10. Influence of cisplatin intrastrand crosslinking on the conformation, thermal stability, and energetics of a 20-mer DNA duplex.
Poklar N; Pilch DS; Lippard SJ; Redding EA; Dunham SU; Breslauer KJ
Proc Natl Acad Sci U S A; 1996 Jul; 93(15):7606-11. PubMed ID: 8755522
[TBL] [Abstract][Full Text] [Related]
11. Unique properties of DNA interstrand cross-links of antitumor oxaliplatin and the effect of chirality of the carrier ligand.
Kasparkova J; Vojtiskova M; Natile G; Brabec V
Chemistry; 2008; 14(4):1330-41. PubMed ID: 18022972
[TBL] [Abstract][Full Text] [Related]
12. NMR solution structure of a DNA dodecamer duplex containing a cis-diammineplatinum(II) d(GpG) intrastrand cross-link, the major adduct of the anticancer drug cisplatin.
Gelasco A; Lippard SJ
Biochemistry; 1998 Jun; 37(26):9230-9. PubMed ID: 9649303
[TBL] [Abstract][Full Text] [Related]
13. Thallium-DNA complexes in aqueous solution. Major or minor groove binding.
Ouameur AA; Nafisi Sh; Mohajerani N; Tajmir-Riahi HA
J Biomol Struct Dyn; 2003 Feb; 20(4):561-5. PubMed ID: 12529154
[TBL] [Abstract][Full Text] [Related]
14. FTIR and circular dichroism spectroscopic study of interaction of 5-fluorouracil with DNA.
Jangir DK; Charak S; Mehrotra R; Kundu S
J Photochem Photobiol B; 2011 Nov; 105(2):143-8. PubMed ID: 21940176
[TBL] [Abstract][Full Text] [Related]
15. DNA binding mode of the cis and trans geometries of new antitumor nonclassical platinum complexes containing piperidine, piperazine, or 4-picoline ligand in cell-free media. Relations to their activity in cancer cell lines.
Kasparkova J; Marini V; Najajreh Y; Gibson D; Brabec V
Biochemistry; 2003 May; 42(20):6321-32. PubMed ID: 12755637
[TBL] [Abstract][Full Text] [Related]
16. Replacement of a thiourea with an amidine group in a monofunctional platinum-acridine antitumor agent. Effect on DNA interactions, DNA adduct recognition and repair.
Kostrhunova H; Malina J; Pickard AJ; Stepankova J; Vojtiskova M; Kasparkova J; Muchova T; Rohlfing ML; Bierbach U; Brabec V
Mol Pharm; 2011 Oct; 8(5):1941-54. PubMed ID: 21806015
[TBL] [Abstract][Full Text] [Related]
17. Raman spectroscopic evaluation of DNA adducts of a platinum containing anticancer drug.
Jangir DK; Mehrotra R
Spectrochim Acta A Mol Biomol Spectrosc; 2014 Sep; 130():386-9. PubMed ID: 24810023
[TBL] [Abstract][Full Text] [Related]
18. Mechanism of cytotoxicity of anticancer platinum drugs: evidence that cis-diamminedichloroplatinum(II) and cis-diammine-(1,1-cyclobutanedicarboxylato)platinum(II) differ only in the kinetics of their interaction with DNA.
Knox RJ; Friedlos F; Lydall DA; Roberts JJ
Cancer Res; 1986 Apr; 46(4 Pt 2):1972-9. PubMed ID: 3512077
[TBL] [Abstract][Full Text] [Related]
19. Platinum-intercalator conjugates: from DNA-targeted cisplatin derivatives to adenine binding complexes as potential modulators of gene regulation.
Baruah H; Barry CG; Bierbach U
Curr Top Med Chem; 2004; 4(15):1537-49. PubMed ID: 15579095
[TBL] [Abstract][Full Text] [Related]
20. [Comparison of DNA complexation with antitumor therapeutic cis-DDP and binuclear bivalent platinum compound containing pyrazine].
Kas'ianenko NA; Aĭa EE; Bogdanov AA; Kosmotynskaia IuV; Iakovlev KI
Mol Biol (Mosk); 2002; 36(4):745-52. PubMed ID: 12173482
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
